Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect (Q40808465)

23 September 2017

title

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect (English)

1 reference

23 September 2017

0 references

angiogenesis inhibitor

1 reference

Vincent L

1

1 reference

23 September 2017

Chen W

2

1 reference

23 September 2017

Hong L

3

1 reference

23 September 2017

Mirshahi F

4

1 reference

23 September 2017

Mishal Z

5

1 reference

23 September 2017

Mirshahi-Khorassani T

6

1 reference

23 September 2017

Vannier JP

7

1 reference

23 September 2017

Soria J

8

1 reference

23 September 2017

Soria C

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

495

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

159-166

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Hypercholesterolemia and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Target molecules for anti-angiogenic therapy: from basic research to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Ongoing trials with matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Signaling angiogenesis via p42/p44 MAP kinase and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

HMEC-1: establishment of an immortalized human microvascular endothelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Oncostatin M induces angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Subcellular localization of RhoA and ezrin at membrane ruffles of human endothelial cells: differential role of collagen and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

The suppression of small GTPase rho signal transduction pathway inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

Signaling angiogenesis via p42/p44 MAP kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902337-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(01)02337-7

1 reference

23 September 2017

1 reference